Market Access
The UK-US drug pricing deal: A welcome step, but not the fin...
The UK-US deal eases medicines pricing uncertainty, lifts NICE threshold, and boosts confidence, but UK pharma still needs pricing reform
Oncology
How blood tests can inform cancer treatment decisions, with ...
Craig Eagle, chief medical officer of Guardant Health, discusses blood as a rich source of biomarker development in cancer prognosis.
R&D
Why drug delivery is biotech’s overlooked challenge – and it...
Delivery innovations don’t just improve outcomes – they reshape the entire therapy ecosystem.
Patients
The NHS, system burden, and a transformation prescription, w...
Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.
Digital
Garbage in, garbage out: The hidden data crisis in pharma
This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
